IFI27L1

Across TCGA pan-cancer cohorts, IFI27L1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IFI27L1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher IFI27L1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IFI27L1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

READ and SKCM are the cancer types where IFI27L1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	All	0.198	0.822	<.001	36	view →
SKCM	DFS	Median	II,III,IV	1.000	0.212	.033	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

IFI27L1–READ (OS)

Open the READ breakdown →